Skip to main content
. 2022 May 5:1–13. doi: 10.1159/000524202

Table 6.

Summary of management of neonates with MIS-N

Management N = 47, N (%)
Anti-inflammatory/anti-infective agents
 Steroid 39 (82.9)
 Immunoglobulin 36 (76.6)
 Antibiotics 25 (53.2)
 Anakinra 4 (8.5)
 Antiviral (remdesivir) 1 (2.1)
Supportive therapies
 Respiratory support 28 (59.6)
 Inotrope 21 (44.7)
 Heparin 19 (40.4)
 iNO 3 (6.4)
 Antihypertensive 2 (4.3)
 Aspirin 2 (4.3)

iNO, inhaled nitric oxide.